Valeant Pharmaceuticals' business model: the repercussions for patients and the health care system, Senate hearing 114-846, Serial no. 114-24, April 27, 2016.

Saved in:

Bibliographic Details
Corporate Author:	United States. Congress. Senate. Special Committee on Aging
Format:	Government Document Book
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], [2022?]

PASCAL Offsite - Use in Reading Room Only

Holdings details from PASCAL Offsite - Use in Reading Room Only
Call Number:	Y 4.AG 4:S.HRG.114-846
Y 4.AG 4:S.HRG.114-846	Available Place a Hold